very very difficult to predict. The market generally seemed to like the recent purchase and will wait till Q3 to really access the impact. I am guessing the revised estimates will be met and thats what I think market is also expecting. So individualized correction for rgen seems unlikely at this point since large firms are giving very bullish signals for this comp to their investors.
Now regarding longs like us it is a difficult call to make. To take off and re-enter is difficult with such high performing companies. For traders like miss novice it is easy since they look at patterns. For me this is not a playing stock.